Preview

L.O. Badalyan Neurological Journal

Advanced search
Fullscreen

For citations:


Kuzenkova L.M., Kurenkov A.L., Uvakina E.V., Fisenko D.A., Chernikov V.V., Semikina E.L., Popovich S.G., Bursagova B.I., Globa O.V., Andreenko N.V., Abdullaeva L.M., Kurova J.A., Adalimova N.S., Nikolenko D.S., Lyalina A.A., Komarova O.V. Results of a two-year comprehensive follow-up in patients with spinal muscular atrophy who received gene therapy with onasemnogen abeparvovec at the presymptomatic stage of the disease. L.O. Badalyan Neurological Journal. 2025;6(4):182-194. (In Russ.) https://doi.org/10.46563/2686-8997-2025-6-4-182-194. EDN: bletts

Views PDF (Rus): 61

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2686-8997 (Print)
ISSN 2712-794X (Online)